Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | PLAU | P00749 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | S100A4 | P26447 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Nitrophenol SCHEMBL5573898 | 0.94 | ESR1 (0.54) | TSHRALDH1A1ALOX15GPR35TDP1 | |
| SCHEMBL4958995 | 0.86 | TSHR (0.52) | TSHRALDH1A1ALOX15GPR35SMN1; SMN2 | |
| Dinitrophenylene SCHEMBL27352655 | 0.84 | LMNA (0.59) | TSHRALDH1A1ALOX15TDP1SMN1; SMN2 | |
| SCHEMBL28257786 | 0.81 | TSHR (0.54) | TSHRALDH1A1ALOX15TDP1LMNA | |
| SCHEMBL4960980 | 0.80 | TDP1 (0.66) | TSHRALDH1A1ALOX15GPR35TDP1 | |
| SCHEMBL8668528 | 0.80 | TSHR (0.66) | TSHRALDH1A1GPR35TDP1SMN1; SMN2 | |
| SCHEMBL774010 | 0.79 | CASP6 (0.58) | TSHRALDH1A1ALOX15GPR35TDP1 | |
| SCHEMBL14375281 | 0.79 | HSD17B10 (0.53) | TSHRALDH1A1TDP1LMNAGAA | |
| SCHEMBL5172969 | 0.79 | ALDH1A1 (0.55) | TSHRALDH1A1ALOX15GPR35TDP1 | |
| SCHEMBL8686354 | 0.79 | TDP1 (0.52) | TSHRALDH1A1ALOX15TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3842076-B1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2023-02-15 | — | — | EP | claimed |
| EP-3558399-B1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2021-01-20 | — | — | EP | claimed |
| EP-3338813-B1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2020-01-29 | — | — | EP | claimed |
| EP-3318532-A1 | METHOD AND DEVICE FOR NO INSTILLATION | BSN medical GmbH (DE) | 2018-05-09 | — | — | EP | claimed |
| EP-3288893-A1 | MULTI-STEP PROCESS FOR NO PRODUCTION | BSN Medical Holding GmbH (DE) | 2018-03-07 | — | — | EP | claimed |
| WO-2016174043-A1 | MULTI-STEP PROCESS FOR NO PRODUCTION | BSN MEDICAL GMBH (DE) | 2016-11-03 | — | — | WO | claimed |
| US-7211414-B2 | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity | VISIGEN BIOTECHNOLOGIES, INC. (US) | 2007-05-01 | — | — | US | claimed |
| EP-3415641-B1 | METHOD FOR ANALYSIS OF MOLECULES | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2023-11-01 | — | — | EP | disclosed |
| EP-3534809-B1 | DEBRIDEMENT DEVICE | BSN MEDICAL GMBH (DE) | 2020-09-02 | — | — | EP | disclosed |
| EP-3458115-B1 | WOUND OR SKIN PATCH | BSN MEDICAL GMBH (DE) | 2020-08-26 | — | — | EP | disclosed |
| EP-3534809-A1 | DEBRIDEMENT DEVICE | BSN Medical GmbH (DE) | 2019-09-11 | — | — | EP | disclosed |
| EP-3288517-B1 | MEDICAL BATHING DEVICE | BSN MEDICAL GMBH (DE) | 2019-07-17 | — | — | EP | disclosed |
| EP-3458115-A1 | WOUND DRESSING OR DERMAL PATCH | BSN Medical GmbH (DE) | 2019-03-27 | — | — | EP | disclosed |
| US-20060061755-A1 | Apparatus and method for analysis of molecules | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2006-03-23 | — | — | US | disclosed |
| US-20060061754-A1 | Arrays of optical confinements and uses thereof | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2006-03-23 | — | — | US | disclosed |
| WO-2004041840-A2 | PEPTIDE-BOUND CHROMOGENS USED FOR DETERMINING ENZYMATIC ACTIVITIES | C-CIT AG (CH) | 2004-05-21 | — | — | WO | disclosed |
| EP-1354064-A2 | ENZYMATIC NUCLEIC ACID SYNTHESIS: COMPOSITIONS AND METHODS FOR ALTERING MONOMER INCORPORATION FIDELITY | Visigen Biotechnologies, Inc. (US) | 2003-10-22 | — | — | EP | disclosed |
| US-20030134807-A1 | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity | Life Technologies Corporation | 2003-07-17 | — | — | US | disclosed |
| WO-2002044425-A2 | ENZYMATIC NUCLEIC ACID SYNTHESIS: COMPOSITIONS AND METHODS FOR ALTERING MONOMER INCORPORATION FIDELITY | VISIGEN BIOTECHNOLOGIES, INC. (US) | 2002-06-06 | — | — | WO | disclosed |
| US-6399335-B1 | MIXING POLYMERASE AND NUCLEOSIDE TRIPHOSPHATE HAVING A GAMMA PHOSPHATE PHOSPHOESTER-LINKED FUNCTIONAL GROUP, INCUBATING SO THAT POLYMERASE CATALYZES CLEAVAGE BETWEEN ALPHA AND BETA PHOSPHATES AND LIBERATES PYROPHOSPHATE WITH FUNCTIONAL GROUP | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. | 2002-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030134807-A1 | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity | RNGTT, PNP, MTAP | TSHR 4361/4885ALDH1A1 1522/4885ALOX15 3324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.